For Opinion, click here for View from the Racetrack Grandstand

Monday, November 10, 2014

BOB KRIVELIN COPS NAADA TROTTING SERIES FINAL

Eight drivers with the most points in the preliminary legs of the North American Amateur Drivers Association’s fall trotting series lined up behind the mobile starting gate at Yonkers Raceway last week on November  6 and they  competed for the $14,000 purse that was offered in the series finale.  Although there was plenty of action in the early going Bob Krivelin, and his trotter Current Crisis, followed cover after the half and then swung three- deep on the final turn and cruised onto an easy six-length triumph in a time of 2:00.1.

When the gate sprung Bob Hechkoff gunned Get Packin to the lead  and they played hardball with Paul Minore who was up behind  Wygant Prince. After a :28.2 first stanza both trotters raced head-to-head by the half in :58.3 and at that point trailing horses moved to the second tier and Get Packin continued to led as Wygant Prince began to fade  and Wygant Prince’s tiring  forced the second tier trailers to got three wide. That group was led by Hannah  Miller and Rev It Now followed by Current Crisis and Jimmer, with Bob Davis at the lines.

When the outer flow came off the final turn Current Crisis began to open up an insurmountable lead which the 8-year old Currant Cast gelding held until the photo finish camera snapped.

Second under the wire was Rev It Now and Jimmer took home the show dough. The race was a non-wagering affair and presented prior to the first race on the betting card

Krivelin, one of the top amateur drivers in the country, has twice represented the United States in the World Cup of Amateur Racing. His win at Yonkers was his 14th this season and 166th of his amateur driving career.


Each year via their trotting series NAADA president, Joe Faraldo makes sure that money is raised for a worthy charity. This season an amount of $7500 was raised and it was matched by Tim Rooney which made a total of $15,000 for the Susan G Komen Race For The Cure of Breast Cancer.